ประกวดราคาการจัดซื้อเวชภัณฑ์ยา Trastuzumab 440 mg จำนวน 60 vial

trastuzumab  trastuzumab emtansine continued to improve invasive disease–free survival and overall survival compared with trastuzumab in patients Descriptions Trastuzumab injection is used to treat HER2-overexpressing new or metastatic breast cancer It can be

trastuzumab emtansine continued to improve invasive disease–free survival and overall survival compared with trastuzumab in patients Trastuzumab is a biologic therapy indicated for the treatment of human epidermal growth factor receptor 2 -positive breast cancer and

Trastuzumab deruxtecan provides durable benefits to patients with heavily pretreated HER2 Interpretation We have shown that 6-month trastuzumab treatment is non-inferior to 12-month treatment in patients with HER2-positive early